R. Coleman Lindsley

Also affiliated with Dana-Farber Cancer Institute

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 30 papers. Top paper: “Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse”.

Expansion, persistence, and efficacy of donor memory-like NK cells infused for posttransplant relapse

Journal of Clinical Investigation(2022)10.1172/jci154334

N/A

3.2DataRank · unranked

139 citations

Grace C. Birch, Guangan Hu, Juliana Vergara Cadavid, Sarah Nikiforow, Joanna Baginska +27 more

Single-cell multi-omics defines the cell-type-specific impact of splicing aberrations in human hematopoietic clonal outgrowths

Cell stem cell(2023)10.1016/j.stem.2023.07.012

N/A

1.5DataRank · unranked

63 citations

Paulina Chamely, Allegra G. Hawkins, Robert F. Stanley, Ariel D. Swett, Saravanan Ganesan +29 more

PPM1D modulates hematopoietic cell fitness and response to DNA damage and is a therapeutic target in myeloid malignancy

Blood(2023)10.1182/blood.2023020331

N/A

1.3DataRank · unranked

48 citations

Adam S. Sperling, Christina Mayerhofer, Marie McConkey, Jana M. Ellegast, Carmen Da Silva +18 more

Prophylactic maintenance with venetoclax/azacitidine after reduced-intensity conditioning allogeneic transplant for high-risk MDS and AML

Blood Advances(2024)10.1182/bloodadvances.2023012120

N/A

1.2DataRank · unranked

46 citations

Haesook T. Kim, H. Moses Murdock, Michela Ansuinelli, Jennifer Brock, Corey Cutler +18 more

Prediction of Risk for Myeloid Malignancy in Clonal Hematopoiesis

NEJM Evidence(2023)10.1056/evidoa2200310

N/A

0.856DataRank · unranked

300 citations

Abhishek Niroula, Donna Neuberg, Waihay J. Wong, R. Coleman Lindsley, Marlise R. Luskin +14 more

Distinct genetic pathways define pre-malignant versus compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

Nature Communications(2021)10.1038/s41467-021-21588-4

N/A

0.780DataRank · unranked

180 citations

Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani +38 more

The clinical and functional effects of TERT variants in myelodysplastic syndrome

Blood(2021)10.1182/blood.2021011075

N/A

0.587DataRank · unranked

49 citations

Mikko Myllymäki, Robert Redd, Shilpa Padmanaban, Druha Karunakaran, Valerie M. Tesmer +19 more

BCOR and BCORL1 Mutations Drive Epigenetic Reprogramming and Oncogenic Signaling by Unlinking PRC1.1 from Target Genes

Blood Cancer Discovery(2021)10.1158/2643-3230.bcd-21-0115

N/A

0.564DataRank · unranked

42 citations

Helen C. Wang, Hannah Q. Karp, Clifford A. Meyer, Paloma Cejas, Micah D. Gearhart +22 more

Utility of targeted gene sequencing to differentiate myeloid malignancies from other cytopenic conditions

Blood Advances(2023)10.1182/bloodadvances.2022008578

N/A

0.543DataRank · unranked

9 citations

Johannes B. Goll, R. Coleman Lindsley, Rafael Bejar, Steffanie H Wilson, Donnie Hebert +20 more

Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

Cancer Discovery(2022)10.1158/2159-8290.cd-21-1631

N/A

0.542DataRank · unranked

36 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

Project EVOLVE: an international analysis of postimmunotherapy lineage switch, an emergent form of relapse in leukemia

Blood(2025)10.1182/blood.2024026655

N/A

0.505DataRank · unranked

28 citations

Alexander W. Rankin, Chloe Hoang, Alexandra Semchenkova, Regina M. Myers, Elena Zerkalenkova +76 more

Donor clonal hematopoiesis and recipient outcomes after transplantation

medRxiv(2021)10.1101/2021.09.25.21263697

N/A

0.425DataRank · unranked

16 citations

Haesook T. Kim, Lin Zhao, H. Moses Murdock, Bryan C. Hambley, Alana F. Ogata +24 more

Combination therapy with hypomethylating agents and venetoclax versus intensive induction chemotherapy in IDH1‐ or IDH2‐mutant newly diagnosed acute myeloid leukemia—A multicenter cohort study

American Journal of Hematology(2024)10.1002/ajh.27366

N/A

0.345DataRank · unranked

9 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.04.134692

N/A

0.292DataRank · unranked

6 citations

Kasiani C. Myers, James R. Bowman, Christopher J. Gibson, Nicholas D. Camarda, Elissa Furutani +38 more

Measurable residual mutated NPM1 before allogeneic transplant for acute myeloid leukemia

Bone Marrow Transplantation(2025)10.1038/s41409-025-02757-1

N/A

0.168DataRank · unranked

2 citations

Gege Gui, Niveditha Ravindra, Georgia Andrew, Devdeep Mukherjee, Zoë C. Wong +23 more

The clinical and functional effects of TERT variants in myelodysplastic syndrome

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.02.11.430624

N/A

0.104DataRank · unranked

1 citations

Mikko Myllymäki, Robert Redd, Shilpa Padmanaban, Druha Karunakaran, Valerie M. Tesmer +18 more

Venetoclax/FluBu2 RIC transplant followed by all-oral venetoclax/decitabine maintenance for poor-risk MDS/AML

Blood Advances(2025)10.1182/bloodadvances.2025018631

N/A

0DataRank · unranked

0 citations

Haesook T. Kim, H. Moses Murdock, Anna Bosch, Kevin M. Panaro, Felicia Lim +20 more

Genomic profiling of a randomized trial of interferon-α vs hydroxyurea in MPN reveals mutation-specific responses

Blood Advances(2021)10.1182/bloodadvances.2021004856

N/A

0DataRank · unranked

64 citations

Vibe Skov, Kristen E. Stevenson, Lillian Werner, William S. Duke, Charles Laurore +27 more

Pretreatment clinical and genetic factors predict early post‐treatment mortality in fit AML patients following induction

American Journal of Hematology(2021)10.1002/ajh.26188

N/A

0DataRank · unranked

2 citations

Yael Flamand, Rahul S. Vedula, Jurjen Versluis, Anne Charles, Kevin Copson +6 more

Allelic Complexity of KMT2A Partial Tandem Duplications in Acute Myeloid Leukemia and Myelodysplastic Syndromes

medRxiv(2021)10.1101/2021.11.01.21265781

N/A

0DataRank · unranked

1 citations

Christopher J. Gibson, H. Moses Murdock, Phani K. Davineni, Marian H. Harris, Eunice S. Wang +5 more

BCOR and BCORL1 mutations disrupt PRC1.1 repressive function in leukemia by unlinking the RING-PCGF1 enzymatic core from target genes

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.03.08.433705

N/A

0DataRank · unranked

0 citations

Helen C. Wang, Clifford A. Meyer, Paloma Cejas, Micah D. Gearhart, Emmalee R. Adelman +21 more

Prediction of Life-threatening and Disabling Bleeding in Patients with Acute Myeloid Leukemia Receiving Intensive Induction Chemotherapy

medRxiv(2021)10.1101/2021.09.24.21263986

N/A

0DataRank · unranked

0 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Rahul S. Vedula +15 more

Germ line predisposition variants occur in myelodysplastic syndrome patients of all ages

Blood(2022)10.1182/blood.2022015790

N/A

0DataRank · unranked

90 citations

Amy M. Trottier, Noel Estrada‐Merly, Matthew Pozsgai, Kelsey E. McNeely, Michael W. Drazer +17 more

Impact of diagnostic genetics on remission MRD and transplantation outcomes in older patients with AML

Blood(2022)10.1182/blood.2021014520

N/A

0DataRank · unranked

74 citations

Haesook T. Kim, Nathan Denlinger, Pankit Vachhani, Bryan C. Hambley, Bryan Manning +18 more

Prediction of life-threatening and disabling bleeding in patients with AML receiving intensive induction chemotherapy

Blood Advances(2022)10.1182/bloodadvances.2021006166

N/A

0DataRank · unranked

25 citations

Manu Pandey, Yael Flamand, J. Erika Haydu, Roger Belizaire, Mark G. Faber +16 more

Outlier Expression of Isoforms by Targeted or Total RNA Sequencing Identifies Clinically Significant Genomic Variants in Hematolymphoid Tumors

Journal of Molecular Diagnostics(2023)10.1016/j.jmoldx.2023.06.007

N/A

0DataRank · unranked

6 citations

Tasos Gogakos, Va Lip, Jonathan M. Tsai, Yen-Der Li, Adam S. Fisch +16 more

Data from Impaired Proteolysis of Noncanonical RAS Proteins Drives Clonal Hematopoietic Transformation

(2023)10.1158/2159-8290.c.6549783

N/A

0DataRank · unranked

0 citations

Rahul S. Vedula, Antonio Cuevas-Navarro, Bin Lü, Simon J. Hogg, Eric Wang +22 more

Intensive induction chemotherapy vs hypomethylating agents in combination with venetoclax in NPM1-mutant AML

Blood Advances(2024)10.1182/bloodadvances.2024012858

N/A

0DataRank · unranked

12 citations

Shai Shimony, Rory M. Shallis, Yiwen Liu, Guillaume Berton, Eva J. Schaefer +18 more

Correlation between peripheral blood and bone marrow mutations among patients with MDS from the National MDS Study

Blood Neoplasia(2024)10.1016/j.bneo.2024.100026

N/A

0DataRank · unranked

1 citations

Johannes B. Goll, Travis L. Jensen, Sridhar Nonavinkere Srivatsan, Nancy Gillis, Gregory A. Abel +14 more

Targeted Informatics for Optimal Detection, Characterization, and Quantification of FLT3 Internal Tandem Duplications Across Multiple Next-Generation Sequencing Platforms

Journal of Molecular Diagnostics(2020)10.1016/j.jmoldx.2020.06.006

N/A

0DataRank · unranked

30 citations

Diane Brackett, David Szeto, Ryan P. Frazier, Allison Macleay, Phani K. Davineni +10 more